Professor
Canada Research Chair Tier 1
Member, Department of Pathology and Laboratory Medicine
Associate Member, the School of Biomedical Engineering
Associate Member, Department of Chemistry
Email: Jay [at] pathology.ubc.ca
Dr. Jay Kizhakkedathu is a Professor and Tier 1 Canada Research Chair in the Department of Pathology and Laboratory Medicine, a Principal Investigator at the Centre for Blood Research (CBR) and an Associate Member with the Department of Chemistry, The School of Biomedical Engineering at the University of British Columbia (UBC), Vancouver, Canada. Dr. Kizhakkedathu is leading a cutting-edge translational research program to innovate materials and therapeutics that can treat and prevent thrombosis, bleeding, immunothrombosis and infection, immunological rejection of organs and cells, and protection of tissues and organs in inflammatory conditions.
Dr. Kizhakkedathu’s research has been published in both fundamental science and clinical journals including the top journals in biomaterials, biotechnology, materials, translation medicine and hematology (~235): Science Translational Medicine, Nature Materials, NatureBiotechnology, Nature Biomedical Engineering, Nature Communications, Blood, Journal of the American Chemical Society, Biomaterials,ACS Nano, ACS Central Science among many others, and several patents (~35) which form the foundation of a few companies.
Dr. Kizhakkedathu has received numerous other awards and recognitions including the Canada Research Chair Tier 1 in Immunomodulating Materials and Immunotherapy, Distinguished Achievement Award in Excellence in Basic Science Research from Faculty of Medicine in 2022, named as a Fellow Biomaterials Science and Engineering (FBSE) (2020) by the World Biomaterials Congress, the UBC Killam Research Prize in 2017, and the Department of Pathology and Laboratory Medicine Excellence in Research and Discovery Award in 2011. He was also recognized as a Michael Smith Foundation for Health Research Scholar (MSFHR) in 2011 and was honoured with the Canadian Institutes of Health Research (CIHR) New Investigator Award in2005.